Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$16.67 USD
-0.07 (-0.42%)
Updated May 3, 2024 04:00 PM ET
After-Market: $16.67 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth D Momentum A VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
CCRN 16.67 -0.07(-0.42%)
Will CCRN be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CCRN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CCRN
Compared to Estimates, Cross Country (CCRN) Q1 Earnings: A Look at Key Metrics
New Strong Sell Stocks for February 27th
CCRN: What are Zacks experts saying now?
Zacks Private Portfolio Services
5 Stocks Favored by Brokers Amid the Current Uncertainty
Cross Country (CCRN) Reports Q4 Earnings: What Key Metrics Have to Say
Curious about Cross Country (CCRN) Q4 Performance? Explore Wall Street Estimates for Key Metrics
Other News for CCRN
Cross Country Healthcare to Attend Benchmark’s Healthcare House Call Investor Conference
Cross Country Healthcare Issues Informative Press Statement
Cross Country Healthcare (CCRN) Gets a Hold from Oppenheimer
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Cross Country Healthcare (CCRN) and CVS Health (CVS)
Truist Financial Remains a Hold on Cross Country Healthcare (CCRN)